RNA splicing and cardiovascular disease: a guide for cardiologists
Listen to this summary
This review explores the role of alternative RNA splicing in cardiovascular disease, focusing on how cardiac-specific splicing programs influence heart development, function, and disease progression. The authors aim to highlight diagnostic and therapeutic opportunities arising from advancements in transcriptomics and splicing modulation strategies, while addressing the challenges of translating these findings into clinical practice for cardiovascular conditions. Ultimately, they position RNA splicing as a promising target for precision medicine in cardiology.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from European heart journal
View all →Jun 11, 2026 · European heart journal
Accelerated epigenetic ageing in congenital heart disease: the AccelerAGE study
Jun 9, 2026 · European heart journal
Statins and survival free of incident frailty among older US veterans
Jun 5, 2026 · European heart journal
ACADM-mediated fatty acid β-oxidation pathway in atherosclerosis and abdominal aortic aneurysm
Jun 5, 2026 · European heart journal
P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis
Jun 5, 2026 · European heart journal
Arrhythmogenic right ventricular cardiomyopathy
Jun 5, 2026 · European heart journal
Extracellular vesicles in atherosclerotic cardiovascular disease: mechanisms and therapeutic implications
More in Internal Medicine
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
